An Open Label Clinical Trial to Evaluate the Efficacy of Vamana Karma in the Management of Urdwaga Amalpitta

Background: Amlapitta is one of the most common & familiar disease of Annavaha Srotas in present era described in various classical Ayurvedic text. The primary cause of Amlapitta is Agnidushti due to Pitta Dosha vitiation, often triggered by faulty dietary habits, stress, and sedentary lifestyle. Traditional management of Amlapitta primarily involves Shodhana along with the Shamana Chikitsa Shodhana Chikitsa (purificatory therapy) is considered more effective for long-term relief and prevention of recurrence. Among the Shodhana therapies, Vaman Karma (therapeutic emesis) is the prime treatment for Kapha and Pitta vitiated disorders. Objective: To evaluate the efficacy of Vamana Karma in the management of Urdhwaga Amlapitta. Methodology: The study was a single-arm open-label clinical trial. A total of 30 patients with cardinal symptoms of Urdhwaga Amlapitta who meet the Vaman Karma criteria, aged 25-50 years of either sex, willing to participate in the study was picked for a 15-day period. Result: Change will be noted in the subjective parameter. Conclusion: Vaman Karma will reduce the symptoms of Urdhwaga-Amlapitta.